Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Hyngstrom

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Surgical Oncology Clinics of North America|May 24, 2025
Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/Resectable Stage IV MelanomaJohn R Hyngstrom
Journal of Surgical Oncology|February 27, 2010
Neoadjuvant strategies for the treatment of locally advanced esophageal cancerJohn R Hyngstrom, Mitchell C Posner
Frontiers in Medicine|April 10, 2026
Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunitiesAdrian P Mansini, John R Hyngstrom, Kyle T Amber
The Journal of Physiology|January 29, 2019
Vasodilatory function in human skeletal muscle feed arteries with advancing age: the role of adropinOh Sung Kwon, Robert H I Andtbacka, John R Hyngstrom, et al.
Melanoma Research|August 31, 2018
Routine retrieval of pelvic sentinel lymph nodes for melanoma rarely adds prognostic information or alters managementDouglas S Swords, Robert H I Andtbacka, Tawnya L Bowles, et al.
American Journal of Surgery|September 4, 2020
Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort studyJosh Bleicher, Elliot A Asare, Shadai Flores, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2020
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodiesKelsey Baron, Justin C Moser, Shiven Patel, et al.
Acta Oncologica (Stockholm, Sweden)|January 11, 2020
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanomaJustin C Moser, Guo Wei, Sarah V Colonna, et al.
American Journal of Surgery|August 22, 2024
The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER Medicare data (2010-2018)Nathan Shen, Siddharth Ramanathan, Joshua J Horns, et al.
The Journal of Physiology|November 23, 2022
Ageing and endothelium-mediated vascular dysfunction: the role of the NADPH oxidasesOh Sung Kwon, Sung Gi Noh, Soung Hun Park, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Surgical Oncology Clinics of North America|May 24, 2025
Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/Resectable Stage IV MelanomaJohn R Hyngstrom
Journal of Surgical Oncology|February 27, 2010
Neoadjuvant strategies for the treatment of locally advanced esophageal cancerJohn R Hyngstrom, Mitchell C Posner
Frontiers in Medicine|April 10, 2026
Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunitiesAdrian P Mansini, John R Hyngstrom, Kyle T Amber
The Journal of Physiology|January 29, 2019
Vasodilatory function in human skeletal muscle feed arteries with advancing age: the role of adropinOh Sung Kwon, Robert H I Andtbacka, John R Hyngstrom, et al.
Melanoma Research|August 31, 2018
Routine retrieval of pelvic sentinel lymph nodes for melanoma rarely adds prognostic information or alters managementDouglas S Swords, Robert H I Andtbacka, Tawnya L Bowles, et al.
American Journal of Surgery|September 4, 2020
Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort studyJosh Bleicher, Elliot A Asare, Shadai Flores, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2020
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodiesKelsey Baron, Justin C Moser, Shiven Patel, et al.
Acta Oncologica (Stockholm, Sweden)|January 11, 2020
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanomaJustin C Moser, Guo Wei, Sarah V Colonna, et al.
American Journal of Surgery|August 22, 2024
The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER Medicare data (2010-2018)Nathan Shen, Siddharth Ramanathan, Joshua J Horns, et al.
The Journal of Physiology|November 23, 2022
Ageing and endothelium-mediated vascular dysfunction: the role of the NADPH oxidasesOh Sung Kwon, Sung Gi Noh, Soung Hun Park, et al.
Pageof 4